Mainz Biomed (MYNZ) Short term Debt (2020 - 2024)
Historic Short term Debt for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $1.0 million.
- Mainz Biomed's Short term Debt fell 7898.74% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 7898.74%. This contributed to the annual value of $1.0 million for FY2024, which is 7898.74% down from last year.
- Latest data reveals that Mainz Biomed reported Short term Debt of $1.0 million as of Q4 2024, which was down 7898.74% from $32140.0 recorded in Q2 2024.
- Mainz Biomed's Short term Debt's 5-year high stood at $4.9 million during Q4 2023, with a 5-year trough of $24527.0 in Q4 2020.
- Its 5-year average for Short term Debt is $749045.6, with a median of $32602.0 in 2023.
- In the last 5 years, Mainz Biomed's Short term Debt plummeted by 9761.93% in 2022 and then skyrocketed by 1499897.14% in 2023.
- Over the past 5 years, Mainz Biomed's Short term Debt (Quarter) stood at $24527.0 in 2020, then surged by 5411.29% to $1.4 million in 2021, then plummeted by 97.62% to $32181.0 in 2022, then skyrocketed by 14998.97% to $4.9 million in 2023, then tumbled by 78.99% to $1.0 million in 2024.
- Its Short term Debt stands at $1.0 million for Q4 2024, versus $32140.0 for Q2 2024 and $4.9 million for Q4 2023.